[go: up one dir, main page]

EA201792173A1 - COMPOSITIONS OF SPRAY FUROAT MOMETHONE FOR LOCAL APPLICATION - Google Patents

COMPOSITIONS OF SPRAY FUROAT MOMETHONE FOR LOCAL APPLICATION

Info

Publication number
EA201792173A1
EA201792173A1 EA201792173A EA201792173A EA201792173A1 EA 201792173 A1 EA201792173 A1 EA 201792173A1 EA 201792173 A EA201792173 A EA 201792173A EA 201792173 A EA201792173 A EA 201792173A EA 201792173 A1 EA201792173 A1 EA 201792173A1
Authority
EA
Eurasian Patent Office
Prior art keywords
compositions
spray
momethone
furoat
local application
Prior art date
Application number
EA201792173A
Other languages
Russian (ru)
Inventor
Лалатенду Паниграхи
Алок Раньян Самал
Ума Совджанья Асапу
Сунил Кумар Гхош
Original Assignee
Др. Редди'С Лабораторис Лимитед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Др. Редди'С Лабораторис Лимитед filed Critical Др. Редди'С Лабораторис Лимитед
Publication of EA201792173A1 publication Critical patent/EA201792173A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Изобретение относится к стабильным быстросохнущим неводным композициям фуроата мометазона для местного применения в форме спрея, причём композиция содержит один или более солюбилизаторов, один или более неводных летучих растворителей и плёнкообразователей или мягчителей. Описаны также способы получения таких композиций. Настоящее изобретение относится также к применению композиций спрея фуроата мометазона для местного применения для лечения псориаза, атопического дерматита (атопической экземы) и других поражений или заболеваний кожи.The invention relates to stable quick-drying non-aqueous compositions of mometasone furoate for topical use in the form of a spray, and the composition contains one or more solubilizers, one or more non-aqueous volatile solvents and film-forming agents or softeners. Methods for making such compositions are also described. The present invention also relates to the use of mometasone furoate spray compositions for topical administration for the treatment of psoriasis, atopic dermatitis (atopic eczema) and other lesions or skin diseases.

EA201792173A 2015-03-31 2016-03-31 COMPOSITIONS OF SPRAY FUROAT MOMETHONE FOR LOCAL APPLICATION EA201792173A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1670CH2015 2015-03-31
PCT/IB2016/051827 WO2016157112A1 (en) 2015-03-31 2016-03-31 Topical spray compositions of mometasone furoate

Publications (1)

Publication Number Publication Date
EA201792173A1 true EA201792173A1 (en) 2018-04-30

Family

ID=57005771

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201792173A EA201792173A1 (en) 2015-03-31 2016-03-31 COMPOSITIONS OF SPRAY FUROAT MOMETHONE FOR LOCAL APPLICATION

Country Status (3)

Country Link
CN (1) CN107613987A (en)
EA (1) EA201792173A1 (en)
WO (1) WO2016157112A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019224035A1 (en) * 2018-05-24 2019-11-28 Almirall, S.A. Topical pharmaceutical compositions comprising a corticosteroid
EP4108234A1 (en) * 2021-06-25 2022-12-28 RaDes GmbH Topical pharmaceutical formulation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6231875B1 (en) * 1998-03-31 2001-05-15 Johnson & Johnson Consumer Companies, Inc. Acidified composition for topical treatment of nail and skin conditions
ES2209812T3 (en) * 1999-02-05 2004-07-01 Cipla Ltd. TOPIC SPRAYINGS CONTAINING A FILMOGENA COMPOSITION.
DK2473161T3 (en) * 2009-08-31 2017-09-11 Dr Reddys Laboratories Ltd TOPICAL FORMULATIONS INCLUDING A STEROID

Also Published As

Publication number Publication date
CN107613987A (en) 2018-01-19
WO2016157112A1 (en) 2016-10-06

Similar Documents

Publication Publication Date Title
EA201990820A1 (en) METHODS FOR TREATING MITOCHONDRIAL AND METABOLIC DISORDERS
PH12018502747A1 (en) Boronic acid derivatives and therapeutic uses thereof
CL2019001709A1 (en) Pyrazole derivatives as malt1 inhibitors.
CR20190318A (en) Benzooxazole derivatives as immunomodulators
EA201691590A1 (en) BENZIMIDAZOL-2-AMINES AS MIDHI INHIBITORS
EA201692422A1 (en) COMPOSITION CONTAINING HEMCITABIN PRESERVATION
CR20190212A (en) 2,4,5-trisubstituted 1,2,4-triazolones useful as inhibitors of dhodh
MX2019004611A (en) Methods and compositions for changing the composition of the skin microbiome using complex mixtures of bacterial strains.
PH12018500177A1 (en) Compositions useful for treating disorders related to kit and pdfgr
EA201692301A1 (en) DERIVATIVES OF BORONIC ACID AND THEIR THERAPEUTIC APPLICATION
EA201492011A1 (en) ANHATIC PHARMACEUTICAL FORMULATIONS FOR LOCAL APPLICATION
EA201692334A1 (en) CORTICOSTEROID COMPOSITIONS FOR LOCAL APPLICATION
BR112015022545A2 (en) pyrazole compounds and the uses thereof
EA201691988A1 (en) DERIVATIVES OF BORONIC ACID AND THEIR THERAPEUTIC APPLICATION
EA201790273A1 (en) FLAGELLIN COMPOSITIONS AND THEIR APPLICATION
EA201890157A1 (en) METHODS OF TREATMENT OF EPITHELIOID CELL TUMORS
MY193175A (en) Apremilast pharmaceutical compositions
MX2017005861A (en) Methods to target transcriptional control at super-enhancer regions.
MX2016003951A (en) Topical spray composition of halobetasol.
EA201890898A1 (en) NEW CONNECTIONS AND CRYPTOPHICINE CONJUGATES, THEIR RECOVERY AND THEIR THERAPEUTIC APPLICATION
EP4477265A3 (en) Methods of treating new-onset plaque type psoriasis using il-17 antagonists
EA201691962A1 (en) AMIDOSED NITROGEN COMPOUNDS AS TNKS1 AND / OR TNKS2 INHIBITORS
EA201791432A1 (en) COMPOSITIONS ON THE BASIS OF MONOMETHYLATE PREPARATION
MX378164B (en) AROMATIC AMIDES OF CARBOXYLIC ACID.
EA201792173A1 (en) COMPOSITIONS OF SPRAY FUROAT MOMETHONE FOR LOCAL APPLICATION